Amanote Research
Register
Sign In
Health Economics and Outcomes Data Requirements in Indolent Non Hodgkins Lymphoma (Inhl) and Chronic Lymphocytic Leukemia (Cll) From United States Payer Perspective
Value in Health
- United Kingdom
doi 10.1016/j.jval.2014.03.1381
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2014
Authors
J Weaver
M Puyear
S Shreay
Publisher
Elsevier BV
Related search
Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin’s Lymphoma and Exposure–Response in CLL
CPT: Pharmacometrics and Systems Pharmacology
Modeling
Simulation
Cardiovascular Medicine
Pharmacology
Cardiology
DNA Methylation Signatures in Chronic Lymphocytic Leukemia (CLL)
Science-Business eXchange
Composite Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Cytometry Part B - Clinical Cytometry
Forensic Medicine
Pathology
Histology
Cell Biology
Cd160 Expression in B Chronic Lymphocytic Leukemia (B-Cll.).
International Journal of Advanced Research
The PI3Kδ INHIBITOR ME-401 ± RITUXIMAB IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL), CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), AND SMALL LYMPHOCYTIC LYMPHOMA (SLL)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Solitary Hepatic Involvement of Histologically and Clinically Indolent Chronic Lymphocytic Leukemia
Tenri Medical Bulletin
Transcend CLL 004: Minimal Residual Disease After Lisocabtagene Maraleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Cost of Disease Progression in Patients With Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non‐Hodgkin's Lymphoma
Oncologist
Cancer Research
Medicine
Oncology
Non Hodgkins Lymphoma: Larynx
Medical Journal Armed Forces India
Medicine
